Carbon monoxide (CO) is a colorless, odorless, tasteless, and non-irritating gas and is formed by inadequate burning of carbon-based fuels \[[@ref1], [@ref2]\]. Motor vehicle exhaust gases, smokes caused by fires, gas powered engines, forest fires, and methylene chloride containing dyes are the most common sources of CO \[[@ref3]\].

CO poisonings constitute 8%--34% of all cases of poisonings \[[@ref4]\]. However, symptoms may vary within a wide spectrum from mild headache to coma \[[@ref5]\].

In the present study, patients with CO poisoning were admitted to the emergency department. The aim of the present study was to determine the demographic, medical, and treatment characteristics of patients and to investigate the relationship between the clinical process and outcome of patients and blood carboxyhemoglobin (COHb), lactate, and troponin levels.

MATERIALS AND METHODS {#sec1-2}
=====================

The study, which was based on dissertation, was conducted retrospectively in the emergency room of the same hospital. The study was approved by the ethics committee of Umraniye Training and Research Hospital. Patients who were aged \>18 years and diagnosed with CO poisoning between 01/01/2013 and 01/01/2016 were included in the study. Patients who did not comply with the inclusion criteria or had inadequate hospital records were excluded from the study.

Based on the data obtained from the scanned patient files and hospital information management system, data related to age; sex; presentation; time of admission; state of consciousness; presence of syncope; blood COHb, troponin, and lactate levels; oxygen treatment method applied to the patients; and patient outcomes were recorded. Data were analyzed using the Statistical Package for Windows, version 23 (SPSS Inc., Chicago, IL, USA) program. In this analysis, while the distributions of data were evaluated by the Shapiro--Wilk test, mean, standard deviation, median, minimum, and maximum values were used for defining continuous variables. Number of patients and percentiles were used in the representation of categorical variables.

Student's t-test was used for comparison of two independent and normally distributed continuous variables, whereas Mann--Whitney U test was used for comparison of two variables that did not conform to normal distribution. Chi-square and Fisher's exact tests were used to examine the relationship between categorical variables. According to the treatment modality, receiver operating characteristic (ROC) analysis was used to evaluate lactate, troponin, and CO levels. Multivariate regression analysis was conducted to analyze the factors affecting the hospitalization of patients. A p value \<0.05 was accepted as statistically significant.

RESULTS {#sec1-3}
=======

A total of 450 patients who had CO poisoning during our study period were detected. It was observed that the data of these patients were not suitable for normal distribution. The median age of the patients was 35 (interquartile range (IQR) 26.75--45.00) years. Female patients constituted 59.1% (n=266) of the study population. Most (64.4%, n=290) of the patients were admitted to the outpatient clinic, whereas 56.67% (n=255) of them consulted the emergency department between 19:01 and 06:59 h and often during the winter months (n=202, 44.89%). Sixty-four (14.2%) patients had syncope, and the Glasgow Coma Scale scores of 22 (22.9%) patients were \<15 ([Table 1](#T1){ref-type="table"}).

###### 

Information of the study patients related to admission and their clinical process

  Variables                                    n     \%
  -------------------------------------------- ----- ------
  Gender                                             
   Male                                        184   40.9
   Female                                      266   59.1
  Types of admission                                 
   Ambulatory                                  290   64.4
   In ambulance                                160   35.6
  Time of presentation                               
   07^01^--19^00^                              195   43.3
   19^01^--07^00^                              255   56.7
  Admission season                                   
   Summer                                      55    12.2
   Fall                                        81    18
   Winter                                      202   44.9
   Spring                                      112   24.9
  Glasgow Coma Score                                 
   15                                          428   95.1
   14                                          17    3.9
   13                                          2     0.4
   12                                          1     0.2
   3                                           2     0.4
  History of syncope                                 
   Yes                                         64    14.2
   No                                          386   85.8
  Type of oxygen therapy                             
   NBO[\*](#t1f1){ref-type="table-fn"}         413   91.8
   NBO+HBO[\*\*](#t1f2){ref-type="table-fn"}   37    8.2
  Outcome                                            
   Discharge                                   440   97.8
   Hospitalization                             10    2.2

Normobaric oxygen;

Hyperbaric oxygen.

Blood levels of COHb (n=450), lactate (n=448), and troponin (n=332) were analyzed in a respective number of patients. The median values of COHb, lactate, and troponin at the time of presentation were 11.80% (IQR 3--23) (range 1.3%--1.5%), 1.60 (IQR 1.10--2.50) (range 1.2--2.2) mmol/l, and 0.00 (IQR 0.000--0.003) (0--0.03) ng/ml, respectively. In our study, the relationships of these biomarkers with normobaric oxygen (NBO) or hyperbaric oxygen (HBO) treatments were also analyzed ([Table 2](#T2){ref-type="table"}). According to these analyses, lactate, troponin, and COHb levels of patients receiving HBO treatment were as follows: 2.20 (IQR 1.55--3.75), 0.001 (IQR 0.000--0.040), and 19.20 (IQR 10.00 (26.50), respectively, and statistically significantly higher than those receiving NBO (Mann--Whitney U, p\<0.01). With the help of ROC analysis, the presence of the threshold values of these levels was investigated ([Fig. 1](#F1){ref-type="fig"}).

###### 

Comparison between serum COHb, lactate, and troponin levels and other data related to the patient and clinical process

  Analysis                            Comparator data                                   No. of patient s tested    Median                     p
  ----------------------------------- ---------------------- -------------------------- -------------------------- -------------------------- ---------
  Serum carboxyhemoglobin level (%)   Type of presentation   Ambulatory                 160                        12.65 (IQR 3.20--23.00)    0.679
  In ambulance                        290                    11.10 (IQR 2.95--23.00)                                                          
  Syncope                             Yes                    64                         16.05 (IQR 5.12--26.82)    0.630                      
  No                                  386                    10.60 (IQR 3.0--22.3)                                                            
  Treatment                           NBO                    413                        10.80 (IQR 2.50--22.40)    0.006                      
  HBO                                 37                     19.20 (IQR 10.00--22.50)                                                         
  Outcome                             Discharge              440                        11.20 (IQR 3.00--22.87)    0.560                      
  Hospitalisation                     10                     22.85 (IQR 14.72--27.85)                                                         
  Serum lactate level (mmol/l)        Type of presentation   Ambulatory                 160                        1.60 (IQR 1.10--2.57)      0.605
  In ambulance                        290                    1.60 (IQR 1.10--2.50)                                                            
  Syncope                             Yes                    64                         1.85 (IQR 1.10--2.87)      0.181                      
  No                                  386                    1.60 IQR 1.10--2.50)                                                             
  Treatment                           NBO                    413                        1.50 (IQR 1.10--2.50)      0.012                      
  HBO                                 37                     2.20 (IQR 1.55--3.75)                                                            
  Outcome                             Discharge              440                        1.60 (IQR 1.10--1.50)      0.022                      
  Hospitalisation                     10                     2.50 (IQR 2.17--4.32)                                                            
  Serum troponin level (ng/ml)        Type of presentation   Ambulatory                 126                        0.000 (IQR 0.000--0.010)   \<0.010
  In ambulance                        206                    0.000 (IQR 0.000--0.010)                                                         
  Syncope                             Yes                    53                         0.001 (IQR 0.000--0.020)   0.010                      
  No                                  260                    0.000 (IQR 0.000--0.002)                                                         
  Treatment                           NBO                    302                        0.000 (IQR 0.000--0.002)   \<0.001                    
  HBO                                 30                     0.001 (IQR 0.000--0.040)                                                         
  Outcome                             Discharge              322                        0.000 (IQR 0.000--0.002)   \<0.001                    
  Hospitalisation                     10                     0.009 (IQR 0.000--2.422)                                                         

COHb: Carboxyhemoglobin; IQR: Interquartile range; NBO: Normobaric oxygen; HBO: Hyperbaric oxygen.
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Accordingly, the areas under the curve drawn for HBO therapy were 0.594 for COHb, 0.641 for lactate, and 0.646 for troponin, but a significant threshold value with high specificity and sensitivity could not be achieved (p=0.088, p=0.011, and p=0.008, respectively) ([Table 3](#T3){ref-type="table"}). The mean values for COHb, lactate, and troponin markers, each according to the status of admission and discharge, were examined separately. Accordingly, the mean values of patients at admission were higher than those discharged. In patients admitted for hospitalization, median lactate, troponin, and COHb values were 1.85 (IQR 1.10--2.87), 0.001 (IQR 0.000--0.020), and 16.05 (IQR 5.12--26.82), respectively ([Table 2](#T2){ref-type="table"}). The median levels of each parameter were statistically significantly higher than those of discharged patients (Mann--Whitney U, p\<0.01).

###### 

ROC analyses performed separately for lactate, troponin, and CO levels in patients receiving HBO and NBO treatments

                     AUC     95% CI         p
  ------------------ ------- -------------- -------
  COHb (%)           0.594   0.540--0.741   0.088
  Lactate (mmol/l)   0.641   0.495--0.694   0.011
  Troponin (ng/ml)   0.646   0.530--0.762   0.008

AUC: Area under curve; CI: Confidence interval.

DISCUSSION {#sec1-4}
==========

CO poisoning is the most important cause of poisoning-related mortality in our country as it is worldwide \[[@ref1], [@ref3]\].

In some studies, it has been reported that the average age of the adult population who were admitted to the emergency service with CO poisoning varies between 27 and 41.7 years and consists mainly of female patients \[[@ref6]--[@ref8]\]. Our study has also yielded similar results with respect to age and gender of the poisoned population. The fact that most of the poisonings in our study occurred at night and female patients more frequently referred to hospitals with symptoms of poisoning may be related to greater contribution of men working late at night and women spending more time at home compared with men. Therefore, women are more frequently exposed to sources of CO, such as combi boiler and stoves that use natural gas.

Signs and symptoms of CO poisoning may be nonspecific and variable. In their study on CO poisoning in children, Besli et al. detected a correlation between increased lactate levels and neurological signs \[[@ref9]\]. In the study by Benaissa et al., lactate levels were found to be significantly higher in patients with CO poisoning who developed neurological symptoms, but the clinical significance was reported to be controversial due to the slight increase in lactate levels \[[@ref10]\]. In another study examining syncope development, an increased frequency of syncope was observed in patients with high COHb levels (especially ≥20%) \[[@ref6]\]. Contrary to this observation, in our study, although the frequency of syncope was observed to be as high as 14%, it was found that the development of syncope did not correlate with COHb levels. However, our finding of higher level of troponin in these patients, in consideration of the half-life, and production of CO may be related to the time elapsed after exposure to CO gas, which affected negatively lactate and COHb and positively troponin levels.

HBO is one of the most important treatments for CO poisoning. There are several studies reporting different opinions comparing NBO and HBO therapy in the literature. In a Cochrane review, six randomized controlled trials were examined and any clear-cut evidence indicating that HBO alleviates the neurological side effects of CO poisoning \[[@ref11]\]. However, Repplinger et al. suggested that lactate can be used for HBO therapy \[[@ref12]\]. Although our study did not question the success of the treatment, it was observed that patients who were referred for HBO treatment had high COHb, lactate, and troponin levels, and it was important in that this observation demonstrated our physicians' choice of treatment. In fact, the detection of COHb, lactate, and troponin levels in each patient whom we think has CO poisoning may be useful with respect to treatment planning and decision-making process for admission or discharge.

Retrospective design of our study, missing file records, failure to bring the patients who died at the event site to our hospital, and lack of any information about the final status of the patients restrict our interpretation. The fact that patients who were brought to our hospital were not included in our study despite the fact that their file records were not lost, and also after the hospitalization in the emergency room, the final status (e.g., referral to an external center and exitus) of the patients restrict our interpretation.

In conclusion, our study has reflected some demographic, medical, and therapeutic characteristics of the patients presented with CO poisoning, which are frequently encountered in both press and organization of emergency services, and reinforced the need for hospitalization and follow-up of the patients with elevated blood COHb, lactate, and troponin levels.
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